Jason Ruth invests in mid- and late-stage biotechnology companies at Wellington Management. He previously was a partner at MRL Ventures, invested at 5AM Ventures, and conducted cancer research at the Broad Institute.
Jason Ruth invests in mid- and late-stage biotechnology companies at Wellington Management. He previously was a partner at MRL Ventures, invested at 5AM Ventures, and conducted cancer research at the Broad Institute.
Career
Jason Ruth holds a PhD, Biomedical Engineering from University of Pennsylvania and a BS, Bioengineering from University of California, Irvine.
ECScientific Advisory Board Member at Every Cure until Present
MVPartner at MRL Ventures from 2022 to 2024
5VInvestor at 5AM Ventures from 2017 to 2022
BICancer Researcher at Broad Institute from 2014 to 2016